What is the CVSS score of CVE-2022-38765?

CVE-2022-38765 has a CVSS 3.1 base score of 6.5 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N. EPSS exploitation probability: 0.5%.

Vitrea View CVE-2022-38765

MEDIUM

Authorization Bypass Through User-Controlled Key (CWE-639)

2022-12-09 cve@mitre.org

Authentication Bypass Vitrea View

6.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

6.5 MEDIUM

AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

None

Availability

None

Lifecycle Timeline

CVE Published

Dec 09, 2022 - 00:15 nvd

MEDIUM 6.5

DescriptionNVD

Canon Medical Informatics Vitrea Vision 7.7.76.1 does not adequately enforce access controls. An authenticated user is able to gain unauthorized access to imaging records by tampering with the vitrea-view/studies/search patientId parameter.

AnalysisAI

Canon Medical Informatics Vitrea Vision 7.7.76.1 does not adequately enforce access controls. Rated medium severity (CVSS 6.5), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-639. Canon Medical Informatics Vitrea Vision 7.7.76.1 does not adequately enforce access controls. An authenticated user is able to gain unauthorized access to imaging records by tampering with the vitrea-view/studies/search patientId parameter. Affected products include: Canon Vitrea View.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.